US › Healthcare

Quanterix Corp (QTRX)

US · Healthcare · Medical Devices

$3.710.00%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$36.4M
Revenue YoY
+20.3%
Net profit
$-17.5M
Profit YoY
+14.5%
EPS
$0.16
EPS estimate
$-0.62
Net margin
-48.2%

EPS came in at 0.16 against a street estimate of -0.62 — a beat of 125.8%.

Key statistics

Market cap
$174.8M
Forward P/E
0.0
P/B
0.58
Book value
$6.00
EPS (TTM)
$-2.35
52-week high
$8.77
52-week low
$2.40
50-day MA
$3.56
200-day MA
$4.94
Beta
1.07

Analyst view

Analysts rate Quanterix Corp a buy (2 buy, 2 hold, 0 sell out of 4) with an average price target of $4.33.

Shareholding

Insiders
6.32%
Institutions
80.14%

Largest institutional holders

FundStake
Ameriprise Financial Inc7.52%
BlackRock Inc6.96%
Portolan Capital Management, LLC6.25%
Blue Water Life Science Advisors, LLC4.55%
William Blair Investment Management, LLC4.42%
Invenomic Capital Management, LP4.10%
Vanguard Capital Management, LLC3.79%
Arnhold & S. Bleichroeder Advisers, LLC2.76%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Quanterix Corp — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.